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Abstract 
 
Objective 
Neuropeptide Y regulates numerous processes including food intake, body composition, and 
reproduction by at least five different Y receptors. We previously demonstrated a synergistic 
interaction between Y2 and Y4 receptors in reducing adiposity in chow- or fat-fed Y2Y4-
receptor double-knockout mice. In the present study, we investigated whether this synergy 
could reduce the massive obesity of leptin-deficient ob/ob mice. 
 
Methods 
Mice with germline deletions of Y2 and Y4 receptors were crossed onto the ob/ob strain. Body 
weight was measured weekly until 15–18 wk of age before decapitation for collection of trunk 
blood and tissues. 
 
Results 
Male and female Y24ob triple mutants showed highly significant reductions in body weight and 
white adipose tissue mass compared with ob/ob mice. This reduction in body weight was not 
evident in Y2ob or Y4ob double mutants, and the effect on adiposity was significantly greater 
than that seen in Y2ob or Y4ob mice. These changes were associated with significant 
attenuation of the increased brown adipose tissue mass and small intestinal hypertrophy seen 
in ob/ob mice and with normalization of the low circulating free thyroxine concentrations seen 
in female ob/ob mice and the high circulating corticosterone concentrations seen in male ob/ob 
mice. 
 
Conclusion 
These data reveal a synergistic interaction between Y2 and Y4 receptors in attenuating the 
massive obesity of ob/ob mice, possibly mediated by stimulation of thyroid function and 
inhibition of intestinal nutrient absorption. Dual pharmacologic antagonism of Y2 and Y4 
receptors could help people to attain and maintain a healthy weight. 
 
Introduction 
 
 Neuropeptide Y (NPY) regulates numerous processes including food intake, energy 
expenditure, fuel partitioning, reproduction, and growth [1], [2], [3], [4] and [5]. These effects 
are mediated by at least five different Y receptors whose specific functions and interactions are 
not yet fully understood. The Y2 and Y4 receptors have attracted increasing attention in recent 
years as potential targets for antiobesity treatments. This is partly due to reports that other 
members of the NPY family, the gut hormones peptide YY and pancreatic polypeptide, have 
been shown to suppress appetite, primarily by stimulating the Y2 and Y4 receptors, 
respectively [6] and [7]. 
 We previously demonstrated a synergistic interaction between Y2 and Y4 receptors in 
regulating adiposity and bone mass, where Y2Y4-receptor double-knockout mice had a more 
pronounced lean phenotype and enhanced osteoblastic activity than that observed in Y2- or 
Y4-receptor single-knockout mice [8]. The reduction in adiposity in Y2Y4-receptor double-
knockout mice occurred despite no change in physical activity. Deletion of the Y2 and Y4 
receptors also protected against diet-induced obesity and this synergy was strong enough to 
counteract the obesogenic effect of Y1-receptor deficiency [9]. Y2Y4 knockout mice 
demonstrated improved glucose tolerance on a high-fat diet compared with wild-type mice [9]. 
Interestingly, they also showed increased fecal levels of free fatty acids associated with 
reduced bile acid pool and changes in intestinal morphology, suggesting impairment in the 
absorption of digested lipids [9]. However, it is likely that changes in the expression of pro-
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opiomelanocortin (POMC) contribute at least in part to the lack of obesity in these mice. 
Although high-fat feeding in wild-type mice results in decreased expression of NPY and POMC 
in the arcuate nucleus, these changes are absent in Y2Y4 double-knockout mice [9]. A 
protective role for increased POMC expression against diet-induced obesity has also been 
shown by others [10], and decreases in POMC signaling are seen in genetically obese ob/ob 
and db/db mice [11]. 
 Leptin-deficient, genetically obese ob/ob mice show an obese phenotype with 
chronically elevated hypothalamic NPY levels due to the lack of leptin's inhibitory action on 
NPY expression [12]. Deleting the Y2 [13] but not the Y4 [14] receptor has been shown to 
partially attenuate this phenotype. Body weight, food intake, low testosterone levels, and 
infertility of ob/ob mice were unaltered by deletion of the Y2 receptor [13]. However, Y2-
receptor deletion attenuated the adiposity, hyperinsulinemia, hyperglycemia, low circulating 
insulin-like growth factor-1 (IGF-1) levels, lean tissue mass, and increased hypothalamo-
pituitary-adrenal axis activity of ob/ob mice [13]. In addition, although Y2ob mice had elevated 
NPY expression similar to that of ob/ob mice, POMC expression in the arcuate nucleus was 
significantly increased compared with ob/ob mice, consistent with the attenuated adiposity [13]. 
In contrast, deletion of the Y4 receptor on the ob/ob background rescued the infertility of ob/ob 
mice, with no effect on fat mass, insulinemia, or glycemia [14]. 
 Our findings with Y2Y4 double-knockout mice under lean and diet-induced obesity 
conditions suggest that the dual antagonism of Y2 and Y4 receptors would provide the 
greatest antiobesity benefits in genetic obesity. Combined with the fact that Y2-receptor 
deletion attenuated different aspects of the ob/ob phenotype from Y4-receptor deletion, we 
propose that dual Y2- and Y4-receptor deletion would be able to reduce the phenotype of 
genetically obese ob/ob mice to a greater extent that deletion of any one Y receptor. If true, 
this could have a great effect on the development of antiobesity treatments. To test this 
hypothesis, we generated ob/ob mice that were deficient in the Y2 and Y4 receptors (Y24ob 
mice) and analyzed the magnitude of the obese phenotype compared with ob/ob mice. 
 In addition, it is now well established that leptin can markedly influence the regulation 
of bone mass with differing effects on cortical versus cancellous bone [15]. Although leptin 
deficiency in ob/ob mice results in increased cancellous bone volume, it reduces cortical bone 
mass as evidenced by reduced total body bone mineral density, reduced long bone mineral 
content, cortical area, and before cortical area. Therefore, combined with the fact that we 
previously reported a synergistic interaction between the Y2 and Y4 receptors in the regulation 
of bone volume [8], we investigated the bone phenotype of the Y24ob mice. 
 
Materials and methods 
 
Animals 
 Generation of Y2-, Y4-, and Y2- and Y4-receptor double-knockout mice has been 
published previously [8]. These mice were crossed with male and female heterozygous 
(OB/ob) mice on the same mixed C57BL/6-129/SvJ background to obtain Y2−/−ob/ob and 
Y4−/−ob/ob mice as previously described [13] and [14]. Triple heterozygous (Y2+/−Y4+/−OB/ob) 
animals were crossed again to eventually obtain Y2−/−Y4−/−OB/ob animals, which were then 
bred to obtain triple knockouts. The ob genotype was determined by restriction fragment-length 
polymorphism analysis as previously described [13]. 
 All research and animal care procedures were approved by the Garvan Institute/St. 
Vincent's Hospital animal ethics committee. Mice were housed under conditions of controlled 
temperature (22°C) and illumination (12-h light cycle, lights on at 0700 h). All mice were fed a 
normal chow diet ad libitum (6% calories from fat, 21% calories from protein, 71% calories 
from carbohydrates, 2.6 kcal/g; Gordon's Speciality Stock Feeds, Yanderra, NSW, Australia). 
Body weight was measured weekly from 4–6 wk of age onward. 
 
Tissue collection and analysis 
 At 15–18 wk of age, animals were sacrificed by cervical dislocation for the collection of 
trunk blood between 1100 and 1600 h. Brains were immediately removed and frozen on dry 
ice. White adipose tissue (WAT) deposits (right inguinal, right epididymal or right periovarian, 
right retroperitoneal and mesenteric) and the interscapular brown adipose tissue (BAT) were 
dissected out and weighed. The small intestine was excised, its length measured, then flushed 
with isotonic saline, blotted on paper towels, and then weighed with other internal organs. 
 
Bone densitometry 
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 Whole femoral bone mineral content and bone mineral density were measured in 
excised left femora using a dedicated mouse dual X-ray absorptiometer (Lunar Piximus II, GE 
Medical Systems, Madison, WI, USA). Femora were scanned with tibiae attached and the 
knee joint in flexion to 90 degrees, to ensure consistent placement and scanning of the sagittal 
profile. 
 
Serum analyses 
 Serum hormone levels were determined with commercial radioimmunoassay kits from 
ICN Biomedicals (Costa Mesa, CA, USA; corticosterone, free thyroxine [T4], testosterone) and 
Bioclone Australia (Marrickville, Australia; IGF-1). 
 
Statistical analyses 
 All data are expressed as mean ± SEM. Differences among groups of mice were 
assessed by analysis of variance or repeated measures analysis of variance, followed by 
Fisher's post hoc comparisons if appropriate (StatView 4.5, Abacus Concepts Inc., Berkeley, 
CA, USA). Statistical significance was defined as P < 0.05. 
 
Results 
 
Reduced body weight and adiposity in Y24ob mice 
 The combination of Y2- and Y4-receptor deficiency had a strong impact on the body 
weight and adiposity of ob/ob mice, as shown in Figure 1. Despite a significantly greater body 
weight at 4 wk of age, Y24ob mice of both sexes demonstrated a slower rate of body weight 
increase than ob/ob mice or the double-mutant Y2ob and Y4ob animals ( Fig. 1A). Consistent 
with their lower body weight, male and female Y24ob mice exhibited significant reductions in 
the sum of WAT mass compared with ob/ob mice ( Fig. 1B). This reduction was even greater 
than that observed when only the Y2 receptor was deleted on the ob/ob background and was 
also evident when WAT mass was expressed as a percentage of body weight (male wild-type 
2.00 ± 0.10; male ob/ob 8.14 ± 0.31, P < 0.001 versus wild-type mice; male Y24ob 6.61 ± 0.38, 
P < 0.001 versus wild-type mice, P < 0.001 versus ob/ob mice; female wild-type 2.30 ± 0.20; 
female ob/ob 9.31 ± 0.21, P < 0.001 versus wild-type mice; female Y24ob 8.07 ± 0.32, P < 
0.001 versus wild-type mice P < 0.01 versus ob/ob mice; data are means ± SEMs of ≥10 male 
and ≥5 female mice per group). In the individual WAT depots, the decrease in weight was 
more marked in the epididymal or periovarian and mesenteric regions and the retroperitoneal 
region in males and the inguinal region in females when expressed as absolute weight ( Fig. 
1C) and as percentage of body weight (data not shown). 
 
Reduced BAT weight and normal free T4 levels in Y24ob mice 
 The lower body weight of the Y24ob triple mutants could be due to higher energy 
expenditure due to increased thermogenesis as indicated by significantly lower BAT mass 
compared with ob/ob mice ( Fig. 2A). As an index of hypothalamo-pituitary-thyroid function, an 
important determinant of resting metabolic rate [16], serum free T4 levels were measured. 
Interestingly, female ob/ob mice had significantly lower levels of serum free T4 than their wild-
type counterparts, and this effect of leptin deficiency was normalized with deletion of Y2 and 
Y4 receptors (Table 1). This corresponds with the differences observed in BAT mass. 
However, no difference in free T4 levels was observed among males of any genotype. 
 
Y2 and Y4 receptor deletion reduced intestinal and liver hypertrophy of ob/ob mice 
 The intestinal hypertrophy observed in ob/ob mice was normalized in Y24ob mice as 
shown by intestinal weight ( Fig. 2B) and intestinal length (Fig. 2C). This change in Y24ob mice 
may also have contributed to their leaner phenotype because intestinal mass has been 
positively correlated with nutrient absorptive capacity [17]. In addition, ob/ob mice have 
significantly larger livers than wild-type mice. Male and female Y24ob animals had liver 
weights significantly lower than those in ob/ob mice, albeit still higher than wild-type levels ( 
Table 1). This effect was still apparent when liver weights were expressed as a percentage of 
body weight (data not shown). Kidney weights were also normalized to wild-type levels in 
Y24ob mice, although their pancreas, heart, and stomach weights were no different from ob/ob 
mice when expressed as absolute weight or relative to body weight ( Table 1, data not shown). 
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similar to those of obese ob/ob mice (Table 1). Other markers
of rescued fertility in Y4ob male mice were normalized testes
and seminal vesicle weights [14]. Interestingly, Y24ob mice
demonstrated normalized testes weights, although seminal ves-
icle weights remained low at levels similar to those of ob/ob
mice, as shown in Table 1.
Combined Y2- and Y4-receptor deletion enhances cortical
bone responses to leptin deficiency
The potential for leptin-mediated responses in the
Y2!/!Y4!/! mice was examined after crossing of these
mice onto the leptin-deficient ob/ob background. In cortical
Fig. 1. Reduced body weight and adiposity in Y24ob mice. (A) Body weight curves for male and female mice demonstrate reduced body weight over time
in Y24ob mice versus ob/ob, Y2ob, and Y4ob mice. (B) These animals also show a reduction in total WAT mass, (C) with the weight contribution of
individual WAT depots shown. Data are means " SEMs of !10 male and !5 female mice per group. ##P # 0.01, ###P # 0.001 for Y24ob versus ob/ob.
§P # 0.05, §§§P # 0.001 for Y24ob versus Y2ob and Y4ob. !P # 0.05, !!P # 0.01, !!!P # 0.001 versus WT or as indicated by horizontal bars. WAT,
white adipose tissue; WATe, epididymal or periovarian white adipose tissue; WATi, inguinal white adipose tissue; WATm, mesenteric white adipose tissue;
WATr, retroperitoneal white adipose tissue; WT, wild type.
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bone, Y24ob mice displayed a genotype-specific response.
Femoral bone mass, known to be reduced in ob/ob mice
[15,19], was further reduced after the additional loss of Y2
and Y4 signaling (Fig. 3). Femoral bone mineral density and
bone mineral content were significantly reduced in both
sexes of Y24ob mice compared with the wild type, even in
the absence of correction for body weight. Critically, this
reduction was also evident compared with ob/ob mice, al-
though this failed to be significant in bone mineral content
in Y24ob females (P ! 0.06). This additional reduction
occurred despite no consistent effect of single Y2- or Y4-
receptor deletion on the ob/ob background, suggesting that
even when leptin levels were constant Y2"/"Y4"/" mice
responded more markedly than other genotypes.
Fig. 2. Effect of combined Y2- and Y4-receptor deficiency on BAT mass and intestinal weight and length in ob/ob mice. (A) Male and female Y24ob mice
have a marked reduction in BAT mass compared with ob/ob mice. Intestinal weight (B) and length (C) are normalized to WT levels in Y24ob animals. Data
are means # SEMs of !6 male and !4 female mice per group. !P $ 0.05, !!P $ 0.01, !!!P $ 0.001 versus WT or as indicated by horizontal bars.
BAT, brown adipose tissue; WT, wild-type.
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Effect of Y2- and Y4-receptor deletion on hypercorticosteronemia of ob/ob mice 
 Male ob/ob mice demonstrate significant hypercorticosteronemia and it has been 
shown that Y2- or Y4-receptor deficiency separately can normalize serum levels of 
corticosterone to those of male wild-type mice [13] and [14]. We observed that deleting Y2 and 
Y4 receptors also normalizes serum levels of corticosterone in male ob/ob mice ( Table 1). No 
differences in serum corticosterone levels were observed among female mice of any genotype 
(Table 1). 
 
No effect of Y2- and Y4-receptor deletion on serum levels of IGF-1 and testosterone in ob/ob 
mice 
 Insulin-like growth factor-1 is the main mediator of the growth effects of growth 
hormone and often corresponds with changes in the amount of lean body mass [18]. We 
observed no significant differences in the serum levels of IGF-1 in any of our groups, although 
ob/ob and Y24ob animals of both genders tended to have lower serum IGF-1 levels than lean 
wild types ( Table 1). Because Y4-receptor knockout rescues fertility in ob/ob mice with an 
associated increase in circulating testosterone levels in males [14], we investigated the 
testosterone levels of our Y24ob triple mutant males. Intriguingly, this effect of Y4-receptor 
deficiency was abolished because Y24ob mice had very low serum testosterone levels similar 
to those of obese ob/ob mice ( Table 1). Other markers of rescued fertility in Y4ob male mice 
were normalized testes and seminal vesicle weights [14]. Interestingly, Y24ob mice 
demonstrated normalized testes weights, although seminal vesicle weights remained low at 
levels similar to those of ob/ob mice, as shown in Table 1. 
 
Combined Y2- and Y4-receptor deletion enhances cortical bone responses to leptin deficiency 
The potential for leptin-mediated responses in the Y2−/−Y4−/− mice was examined after 
crossing of these mice onto the leptin-deficient ob/ob background. In cortical bone, Y24ob 
mice displayed a genotype-specific response. Femoral bone mass, known to be reduced in 
ob/ob mice [15] and [19], was further reduced after the additional loss of Y2 and Y4 signaling 
(Fig. 3). Femoral bone mineral density and bone mineral content were significantly reduced in 
both sexes of Y24ob mice compared with the wild type, even in the absence of correction for 
body weight. Critically, this reduction was also evident compared with ob/ob mice, although 
this failed to be significant in bone mineral content in Y24ob females (P = 0.06). This additional 
reduction occurred despite no consistent effect of single Y2- or Y4-receptor deletion on the 
Discussion
This study shows that dual ablation of Y2 and Y4
receptors results in synergistic reductions in body weight
and WAT mass in genetically obese leptin-deficient
ob/ob mice of both genders. Whereas Y2- and Y4-recep-
tor dual ablation has been shown to synergistically reduce
the adiposity of mice on a lean background [8] and to
protect against obesity due to a high-fat diet or Y1-
receptor deficiency [9], this study demonstrates the
strength of the antiobesity effect of Y2Y4-receptor dou-
ble ablation in significantly reducing the massive obesity
of ob/ob mice. Other studies have shown that deletion of
individual Y1, Y2, or Y4 but not Y5 [20] receptors can
significantly reduce the body weight or adiposity of ob/ob
mice [13,14,21,22], but no individual Y-receptor knock-
out has been shown to reduce body weight or WAT mass
to such a great extent and so consistently in males and
females as Y2 and Y4 dual knockout.
Attenuation of obesity in ob/ob mice by double Y2Y4-
receptor knockout may be related to 1) reduced ingestion
or absorptio of nutrients and/or 2) increased energy
expen iture. Evidence suggests that both pathway con-
tribute to the leaner phenotyp f Y24o animals. Y2Y4-
receptor ablation resulted in synergistic reductions in
intestinal length and/or weight in ob/ b animals. This
finding extends pr vious work t show that not only on a
lean background [9] but also o a g n tically obese
background, Y2 and Y4 receptors interact in the regula-
tion of gut function and morphology. The markedly re-
duced gut size in Y24ob mice may have contributed to
their leaner phenotype by reducing nutrient absorption,
because increases in intestinal mass in ob/ob mice cor-
relate with increased absorption of all nutrient groups
[17]. In addition to possibly reduced nutrient absorption,
reduced food intake may have contributed to the lean
phenotype of Y24ob mice. Indeed, whereas individual
deletion of Y2 receptors does not have any significant
effect on the hyperphagia of ob/ob mice [13,22], and
Y4-receptor deletion reduces the food intake of male but
not of female ob/ob mice [14], double deletion of Y2 and
Y4 receptors in lean mice results in marked and signifi-
cant reductions in chow or high-fat food intake [9].
The synergistic effects of Y2- and Y4-receptor dele-
tion to reduce body weight and adiposity in ob/ob mice
were associated with marked and significant reductions in
BAT mass. Because reduced BAT mass and increased
BAT expression of uncoupling protein-1 are frequently
associated in conditions of increased energy expenditure,
it is possible that increases in energy expenditure may
have contributed to the antiobesity effects of Y2- and
Y4-receptor dual deletion. In keeping with this, male and
female Y24ob mice demonstrated circulating free T4 lev-
els no different from those of lean wild-type mice, and in
female mice this represents a significant increase in the
low free T4 levels of b/ob mice. Because fr e T4 levels
are an indicator of activity of the hypothalamo-pituitary-
thyroid axis, an important regulator of thermogenesis and
et bolic rate [16], it is possible that Y2Y4-receptor
knockout reduced adip sity in ob/ob mice by increased
Table 1
Comparison of serum parameters and organ weights in Y24ob and control wild-type and ob/ob mice*
Wild type ob/ob Y24ob
Males
Corticosterone (ng/mL) 78.58 ! 16.18 472.41 ! 119.66§ 124.47 ! 35.64¶
Free T4 (pmol/L) 15.51 ! 1.55 15.81 ! 2.79 15.34 ! 2.06
IGF-1 (ng/mL) 374.45 ! 55.13 293.39 ! 26.15 274.90 ! 40.27
Testosterone (ng/mL) 11.15 ! 4.39 2.13 ! 0.74‡ 1.14 ! 0.47‡
Liver (g) 1.29 ! 0.03 4.63 ! 0.34§ 3.35 ! 0.18§#
Kidney (g) 0.34 ! 0.03 0.44 ! 0.04† 0.26 ! 0.01#
Pancreas (g) 0.33 ! 0.02 0.41 ! 0.03‡ 0.40 ! 0.02†
Testes (g) 0.240 ! 0.009 0.202 ! 0.011† 0.247 ! 0.004!
Seminal vesicle (g) 0.35 ! 0.03 0.18 ! 0.02§ 0.20 ! 0.01§
Females
Corticosterone (ng/mL) 155.47 ! 16.60 162.06 ! 30.19 196.25 ! 25.72
Free T4 (pmol/L) 21.09 ! 2.60 10.65 ! 1.85‡ 19.41 ! 3.37!
IGF-1 (ng/mL) 335.74 ! 26.17 271.58 ! 46.71 223.93 ! 33.80
Liver (g) 1.06 ! 0.03 4.11 ! 0.43§ 2.34 ! 0.23§#
Kidney (g) 0.22 ! 0.03 0.39 ! 0.04§ 0.18 ! 0.02#
Pancreas (g) 0.26 ! 0.01 0.35 ! 0.02‡ 0.36 ! 0.04‡
IGF-1, insulin-like growth factor-1; T4, thyroxine
* Data are means ! SEMs of at least six male and at least five female mice per group.
† P " 0.05 versus wild-type mice.
‡ P " 0.01 versus wild-type mice.
§ P " 0.001 versus wild-type mice.
! P " 0.05 versus ob/ob mice.
¶ P " 0.01 versus ob/ob mice.
# P " 0.001 versus ob/ob mice.
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responded more markedly than other genotypes. 
 
 
Discussion 
 This study shows that dual ablation of Y2 and Y4 receptors results in synergistic 
reductions in body weight and WAT mass in genetically obese leptin-deficient ob/ob mice of 
both genders. Whereas Y2- and Y4-receptor dual ablation has been shown to synergistically 
reduce the adiposity of mice on a lean background [8] and to protect against obesity due to a 
high-fat diet or Y1-receptor deficiency [9], this study demonstrates the strength of the 
antiobesity effect of Y2Y4-receptor double ablation in significantly reducing the massive 
obesity of ob/ob mice. Other studies have shown that deletion of individual Y1, Y2, or Y4 but 
not Y5 [20] receptors can significantly reduce the body weight or adiposity of ob/ob mice [13], 
[14], [21] and [22], but no individual Y-receptor knockout has been shown to reduce body 
weight or WAT mass to such a great extent and so consistently in males and females as Y2 
and Y4 dual knockout. 
 Attenuation of obesity in ob/ob mice by double Y2Y4-receptor knockout may be related 
to 1) reduced ingestion or absorption of nutrients and/or 2) increased energy expenditure. 
Evidence suggests that both pathways contribute to the leaner phenotype of Y24ob animals. 
Y2Y4-receptor ablation resulted in synergistic reductions in intestinal length and/or weight in 
ob/ob animals. This finding extends previous work to show that not only on a lean background 
[9] but also on a genetically obese background, Y2 and Y4 receptors interact in the regulation 
of gut function and morphology. The markedly reduced gut size in Y24ob mice may have 
contributed to their leaner phenotype by reducing nutrient absorption, because increases in 
intestinal mass in ob/ob mice correlate with increased absorption of all nutrient groups [17]. In 
addition to possibly reduced nutrient absorption, reduced food intake may have contributed to 
the lean phenotype of Y24ob mice. Indeed, whereas individual deletion of Y2 receptors does 
not have any significant effect on the hyperphagia of ob/ob mice [13] and [22], and Y4-receptor 
deletion reduces the food intake of male but not of female ob/ob mice [14], double deletion of 
Y2 and Y4 receptors in lean mice results in marked and significant reductions in chow or high-
fat food intake [9]. 
 
thyroid function a d metabolic rate. This effect is prob-
ably mediated within the hypothalamus by Y4 but not Y2
receptors, because male Y4- or Y2Y4-receptor knockout
mice on a lean background show significant increases in
expression of thyrotropin-releasing hormone in the hypo-
thalamic paraventricular nucleus, whereas male Y2-receptor
knockout mice show marked decreases in paraventricular
nuclear thyrotropin-releasing hormone mRNA levels [8,13].
We previously reported that the synergy between Y2 and
Y4 receptors in reducing adiposity may be related to differen-
tial effects on the hypothalamo-pituitary-somatotropic and -go-
nadotropic axes [23,24], both of which are inhibited by NPY
[3]. In two conditions of elevated hypothalamic NPY expres-
sion (24-h fasting and leptin-deficient obesity) [12], ger lin
or hyp thalamus-specific Y2- but not Y4-receptor deletion
prevents the associated decrease in activity of the somatotr pic
axis, whereas Y4- but not Y2-receptor deletion prevents the
associated decrease in activity of the gonadotropic axis
[13,14,23]. In our Y24ob mice, measurements of circulating
IGF-1, the main mediator of the growth-promoting effects of
growth hormone [18] and testosterone, do not suggest any
increases in the activity of the somatotropic or gonadotropic
axes relative to ob/ob mice. However, it cannot be excluded
that stimulation in the activity of these ax s independently of
total IGF-1 or total testosterone levels as measured in this study
(for instance, changes in the circulating ratio of free to bound
hormone) may have contributed to the lean phenotype of
Y24ob mice. Indeed, Y2Y4-receptor double deletion normal-
ized the reduced testicular weight of ob/ob mice.
Another means by which Y2 and Y4 receptors may interact
in the reduction of massive obesity in ob/ob mice is by the
additive effects mediated in central and peripheral sites. It was
recently shown that sympathetically derived NPY acts directly
on adipose tissue to promote fat accu ulation under stress
conditions in a glucocorticoid-dependent pathway, and that
this eff ct is attenuat d by pharmac logic ntagonism or ge-
netic ablation of Y2 receptors [25]. Th refore, it is possible that
in Y24ob mice a lack of Y2 receptors on WAT attenuated
these adipogenic effects of NPY. The normalization of circu-
lating corticosterone levels seen in Y24ob mice per se is
unlikely to account for their dramatically reduced adiposity,
because Y2ob and Y4ob mice also show normalization of
corticosterone concentrations [13,14] but only a slight reduc-
tion in adiposity. Therefore, with the lack of Y4 receptors in
Fig. 3. Synergistic effect of combined Y2- and Y4-receptor deficiency on femoral BMC and BMD in ob/ob mice. Femoral BMC (A) and BMD (B) are
significantly reduced in male Y24ob mice compared with ob/ob and WT mice, with a similar trend observed in female Y24ob mice. Data are means! SEMs
of !6 male and !4 female mice per group. !P " 0.05, !!P " 0.01, !!!P " 0.001 versus WT or as indicated by horizontal bars. BMC, bone mineral
content; BMD, bone mineral density; WT, wild-type.
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 The synergistic effects of Y2- and Y4-receptor deletion to reduce body weight and 
adiposity in ob/ob mice were associated with marked and significant reductions in BAT mass. 
Because reduced BAT mass and increased BAT expression of uncoupling protein-1 are 
frequently associated in conditions of increased energy expenditure, it is possible that 
increases in energy expenditure may have contributed to the antiobesity effects of Y2- and Y4-
receptor dual deletion. In keeping with this, male and female Y24ob mice demonstrated 
circulating free T4 levels no different from those of lean wild-type mice, and in female mice this 
represents a significant increase in the low free T4 levels of ob/ob mice. Because free T4 levels 
are an indicator of activity of the hypothalamo-pituitary-thyroid axis, an important regulator of 
thermogenesis and metabolic rate [16], it is possible that Y2Y4-receptor knockout reduced 
adiposity in ob/ob mice by increased thyroid function and metabolic rate. This effect is probably 
mediated within the hypothalamus by Y4 but not Y2 receptors, because male Y4- or Y2Y4-
receptor knockout mice on a lean background show significant increases in expression of 
thyrotropin-releasing hormone in the hypothalamic paraventricular nucleus, whereas male Y2-
receptor knockout mice show marked decreases in paraventricular nuclear thyrotropin-
releasing hormone mRNA levels [8] and [13]. 
 We previously reported that the synergy between Y2 and Y4 receptors in reducing 
adiposity may be related to differential effects on the hypothalamo-pituitary-somatotropic and -
gonadotropic axes [23] and [24], both of which are inhibited by NPY [3]. In two conditions of 
elevated hypothalamic NPY expression (24-h fasting and leptin-deficient obesity) [12], 
germline or hypothalamus-specific Y2- but not Y4-receptor deletion prevents the associated 
decrease in activity of the somatotropic axis, whereas Y4- but not Y2-receptor deletion 
prevents the associated decrease in activity of the gonadotropic axis [13], [14] and [23]. In our 
Y24ob mice, measurements of circulating IGF-1, the main mediator of the growth-promoting 
effects of growth hormone [18] and testosterone, do not suggest any increases in the activity of 
the somatotropic or gonadotropic axes relative to ob/ob mice. However, it cannot be excluded 
that stimulation in the activity of these axes independently of total IGF-1 or total testosterone 
levels as measured in this study (for instance, changes in the circulating ratio of free to bound 
hormone) may have contributed to the lean phenotype of Y24ob mice. Indeed, Y2Y4-receptor 
double deletion normalized the reduced testicular weight of ob/ob mice. 
 Another means by which Y2 and Y4 receptors may interact in the reduction of massive 
obesity in ob/ob mice is by the additive effects mediated in central and peripheral sites. It was 
recently shown that sympathetically derived NPY acts directly on adipose tissue to promote fat 
accumulation under stress conditions in a glucocorticoid-dependent pathway, and that this 
effect is attenuated by pharmacologic antagonism or genetic ablation of Y2 receptors [25]. 
Therefore, it is possible that in Y24ob mice a lack of Y2 receptors on WAT attenuated these 
adipogenic effects of NPY. The normalization of circulating corticosterone levels seen in Y24ob 
mice per se is unlikely to account for their dramatically reduced adiposity, because Y2ob and 
Y4ob mice also show normalization of corticosterone concentrations [13] and [14] but only a 
slight reduction in adiposity. Therefore, with the lack of Y4 receptors in the brain-promoting 
activity of the hypothalamo-pituitary-thyroid and -gonadotropic axes as discussed above, 
combined with the lack of Y2 receptors on adipose tissue inhibiting fat storage by local tissue 
effects [25], Y2Y4 double knockout mice show a lean phenotype that is likely the result of 
several different pathways. 
 In addition to synergistic reductions in body weight and adiposity in Y24ob mice, these 
animals display an exaggerated loss of cortical bone mass compared with that evident in ob/ob 
mice. This response was specific to leptin-deficient Y2Y4-receptor–deficient mice, because 
Y2ob and Y4ob mice were similar to ob/ob mice with respect to cortical bone mass, indicating 
a heightening of the normal skeletal response to leptin deficiency. 
 
Conclusion 
 Deletion of Y2 and Y4 receptors results in synergistic attenuation of the massive 
obesity of ob/ob mice, likely due to a combination of central and peripheral effects. Novel 
combination weight-loss medications that antagonize Y2 and Y4 receptors could help more 
people to attain and maintain a healthy body weight. 
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